Compare ZGN & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZGN | MIR |
|---|---|---|
| Founded | 1910 | 2005 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.9B |
| IPO Year | 2021 | 2020 |
| Metric | ZGN | MIR |
|---|---|---|
| Price | $12.58 | $15.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | $14.31 | ★ $24.27 |
| AVG Volume (30 Days) | 1.1M | ★ 3.1M |
| Earning Date | 09-03-2026 | 10-27-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | N/A | ★ 161.11 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | N/A |
| Revenue This Year | $6.98 | $23.19 |
| Revenue Next Year | $8.18 | $7.31 |
| P/E Ratio | ★ $25.94 | $717.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.64 | $14.04 |
| 52 Week High | $15.95 | $30.28 |
| Indicator | ZGN | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 48.24 | 45.84 |
| Support Level | $11.41 | $14.17 |
| Resistance Level | $13.38 | $16.38 |
| Average True Range (ATR) | 0.36 | 0.65 |
| MACD | 0.11 | -0.17 |
| Stochastic Oscillator | 74.11 | 36.48 |
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of revenue from the Zegna segment.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.